MetaCap

Corcept Therapeutics Incorporated Company Profile

NASDAQ: CORTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

63.62-1.36 (-2.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Corcept Therapeutics at a glance

Corcept Therapeutics Incorporated (NASDAQ: CORT) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Redwood City, CA. Corcept Therapeutics is led by Dr. Joseph K. Belanoff M.D. and employs about 730 people. The company's shares have traded publicly since 2004.

At a market capitalization of $6.96 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001088856, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Corcept Therapeutics do?

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.

Business description based on the company's public filings.

Company information

Legal name
Corcept Therapeutics Incorporated
Ticker
NASDAQ: CORT
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Joseph K. Belanoff M.D.
Employees
730
Headquarters
101 Redwood Shores Parkway, Redwood City, CA, United States
Phone
650 327 3270
IPO year
2004
SEC CIK
0001088856

Companies similar to Corcept Therapeutics

CORT peer companies
CompanyPrice% ChgMarket capCompare
CYTKCytokinetics Incorporated50.78-1.32%$7.07Bvs CORT
AXSMAxsome Therapeutics Inc.129.36-4.66%$6.80Bvs CORT
AMRXAmneal Pharmaceuticals Inc. Class A21.12-1.26%$7.36Bvs CORT
KNSAKiniksa Pharmaceuticals International plc Class A93.90+0.38%$7.38Bvs CORT
ABVXAbivax SA ADR73.20-9.24%$6.41Bvs CORT
ALKSAlkermes plc44.94-2.69%$7.55Bvs CORT
MIRMMirum Pharmaceuticals Inc.96.13+0.65%$6.28Bvs CORT
RYTMRhythm Pharmaceuticals Inc.112.36-3.80%$7.79Bvs CORT

Related